A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment | MicrobiomeTrials
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-11-13Est. Completion: 2027-03-11
Enrollment target: 71 participants
Locations
University of Alabama at Birmingham, Birmingham, Alabama, United States
University of Florida, Gainesville, Florida, United States
Renstar Medical Research, Ocala, Florida, United States
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
University of Kansas Medical Center, Kansas City, Kansas, United States
University of Minnesota, Minneapolis, Minnesota, United States
The Lung Research Center, LLC, Chesterfield, Missouri, United States
University of Missouri Health System, Columbia, Missouri, United States
Columbia University Medical Center-New York Presbyterian Hospital, New York, New York, United States
Weill Cornell Medical College, New York, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Temple University, Philadelphia, Pennsylvania, United States
Clinical Trials Center of Middle Tennessee, LLC, Franklin, Tennessee, United States
University of Virginia Health System, Charlottesville, Virginia, United States
Other microbiome trials you might be interested in